Amiodarone-Induced Hypothyroidism

Amiodarone-Induced Hypothyroidism

Aim: to present a clinical case of amiodarone-induced hypothyroidism in a patient with paroxysmal atrial fi brillation.Results. Before taking amiodarone, the patient suffered from subclinical hypothyroidism. The level of thyroid stimulating hormone (TSH) was 6.2 mIU/L, thyroxine (T4) — 9.2 pmol/L. A...

Full description

Saved in:

Bibliographic Details
Main Authors:	Svetlana A. Chepurnenko, Galina V. Shavkuta, Alina D. Nasytko
Format:	Article
Language:	Russian
Published:	Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2019-12-01
Series:	Кубанский научный медицинский вестник
Subjects:	hypothyroidism amiodarone thyroid hormones paroxysmal atrial fi brillation drug toxicity
Online Access:	https://ksma.elpub.ru/jour/article/view/2021
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Subclinical Hypothyroidism after a Three-Month Course of Low-Dose Amiodarone.
by: Rano Kirkimbayeva, et al.
Published: (2025-03-01)

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment
by: N. N. Isakova, et al.
Published: (2006-06-01)

Thyroidectomy in patients with amiodarone-induced thyrotoxicosis
by: U. A. Tsoy, et al.
Published: (2021-08-01)

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter
by: D. A. Gagloeva, et al.
Published: (2023-05-01)

Subclinical hypothyroidism: treat or watch?
by: I. A. Tsanava, et al.
Published: (2021-03-01)

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION
by: O. V. Gaisenok
Published: (2016-01-01)

Hypothyroidism: from diagnosis to therapy success. A review
by: Elena V. Biryukova, et al.
Published: (2025-01-01)

Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita
by: S. N. Bel'diev
Published: (2016-03-01)

Amiodarone induced lung toxicity: a radiological overview that simulating COVID19 infection disease
by: Marco Umberto Scaramozzino, et al.
Published: (2023-10-01)

Association of iron deficiency with atrial fibrillation recurrence after pharmacological cardioversion
by: M. Kh. Valeev, et al.
Published: (2023-07-01)

ENDOCRINE ASPECTS OF AMIODARONE THERAPY IN CLINICAL PRACTICE (FOLLOW-UP AND TREATMENT ALGORITHM FOR PATIENTS WITH THYROID DYSFUNCTION)
by: N. Yu. Sviridenko, et al.
Published: (2012-04-01)

Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
by: K. G. Adamyan, et al.
Published: (2015-11-01)

Challenges to the Long‐Term Safety Claims of Extremely Low‐Dose Amiodarone: Pulmonary, Thyroid, Hepatic, and Statistical Concerns
by: Malik Abdul Rehman Rasheed, et al.
Published: (2025-08-01)

Subclinical Hypothyroidism Prevalence and Selenium Levels in Women of North Khorasan, Iran: a Cross-Sectional Study
by: Kimiya Hadavi, et al.
Published: (2024-01-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
by: A. G. Pronin, et al.
Published: (2020-12-01)

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
by: D. A. Kuzhel, et al.
Published: (2016-01-01)

INFLUENCE OF «THYREOTON» ON MORPHOLOGICAL CHANGES OF THYROID GLAND IN WHITE RATS WITH EXPERIMENTAL HYPOTHYROIDISM
by: E. V. Arkhipova, et al.
Published: (2012-11-01)

Association of Subclinical Hypothyroidism in Type 2 Diabetic Individuals
by: Noor ul ain, et al.
Published: (2025-02-01)

Association of Subclinical Hypothyroidism in Type 2 Diabetic Individuals
by: Noor ul ain, et al.
Published: (2025-02-01)

THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS
by: O. V. Gaisenok
Published: (2016-01-01)

EFFECTIVENESS AND SAFETY OF PROPAFENONE (PROPANORM®) AND AMIODARONE (CORDARONE®) IN PATIENTS WITH ATRIAL FIBRILLATION, ARTERIAL HYPERTENSION, CORONARY HEART DISEASE, AND CHRONIC HEART FAILURE WITH INTACT LEFT VENTRICULAR SYSTOLIC FUNCTION
by: O. N. Miller, et al.
Published: (2010-08-01)

AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2009-06-01)

Evaluation of the clinical course of hypertensive disorders against the background of subclinical hypothyroidism in pregnant women
by: M. D. Usmanova, et al.
Published: (2024-11-01)

EPIDEMIOLOGICAL CHARACTERISTICS OF SUBCLINICAL HYPOTHYROIDISM
by: Inoyatova Nigina Azizovna, et al.
Published: (2024-12-01)

Maintaining euthyroidism: fundamentals of thyroid hormone physiology, iodine metabolism and hypothyroidism
by: De Wet Wolmarans
Published: (2017-08-01)

Hypothyroidism and gestational diabetes mellitus: Is there a relationship?
by: Vera A. Uchamprina, et al.
Published: (2022-06-01)

Effect of maternal factors on the results of neonatal screening for congenital hypothyroidism in the eastern region of Morocco
by: Wahoud Fatima, et al.
Published: (2025-01-01)

Long‐Term Safety of Extremely Low‐Dose Amiodarone at 50 mg Daily in Patients With Persistent Atrial Fibrillation
by: Kentaro Yoshida, et al.
Published: (2025-08-01)

A questionnaire survey of thyroid specialists in Japan on the use of thyroid hormones in hypothyroid and euthyroid patients
by: Yuji Nagayama, et al.
Published: (2025-08-01)

The Dramatic Outcome of the Late Diagnosis of the Chronic Autoimmune Thyroiditis with the Severe Primary Hypothyroidism
by: E. V. Reznik, et al.
Published: (2023-04-01)

Subclinical/overt hypothyroidism may be associated with diminished ovarian reserve in infertile women independent of thyroid autoimmunity
by: Hongzhan Zhang, et al.
Published: (2024-12-01)

Iatrogenic Primary Hypothyroidism Associated With Sulfamethoxazole‐Trimethoprim Treatment of Nocardiosis in a Cat
by: Deborah Alexander, et al.
Published: (2025-03-01)

Changes in pathophysiology of tumor growth and functional activity of the hypothalamic-pituitary-thyroid axis in rats of both sexes with the development of Guerin's carcinoma on the background of hypothyroidism
by: E. M. Frantsiyants, et al.
Published: (2022-12-01)

Human Amylin as a Novel Diagnostic Marker for Hypothyroidism in Iraqi Patients
by: Duha Khalil Ibrahim, et al.
Published: (2024-07-01)

RETROSPECTIVE EVALUATION OF DIAGNOSTIC METHODS AND TREATMENT OPTIONS IN AMIODARONE-INDUCED THYROTOXICOSIS
by: Nezahat Müge Çatıkkaş, et al.
Published: (2023-08-01)

The relationship between thyroid hormones and lipid profile in subclinical hypothyroidism female patients
by: Kazheen H. Jawzal, et al.
Published: (2022-09-01)

Amiodarone-related keratopathy and optic neuropathy: case report and literature review
by: Nana Meng, et al.
Published: (2025-04-01)

A case of type 2 amiodarone-induced thyrotoxicosis
by: O. O. Soloviuk, et al.
Published: (2024-05-01)

Screening for congenital hypothyroidism by using cord blood thyroid stimulating hormone (CBTSH) levels in neonates
by: Laxmi Gudaganatti, et al.
Published: (2025-04-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
by: Hirota Kida, et al.
Published: (2025-06-01)